1 Neuromedin U and Structural Analogs: an Overview of Their Structure, Function and Selectivity.

2 Dimethyl fumarate mitigates optic neuritis.

3 Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870.

4 Evoked and spontaneous purinergic junctional Ca2+ transients (jCaTs) in rat small arteries.

5 Adrenergic agonists do not compete with the antagonist (−)3-[125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor

6 efektivitas isolat bakteri dari rizosfer dan bahan organik terhadap ralstonia solanacearum dan fusarium oxysporum pada tanaman kentang

7 impacto de herbicidas em isolados de trichoderma spp. impact of herbicides on strains of trichoderma spp.

8 selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects

9 discovery of natural products as novel and potent fxr antagonists by virtual screening

10 p2x4 receptor function in the nervous system and current breakthroughs in pharmacology

11 structural basis for the antiviral activity of bst-2/tetherin and its viral antagonism

12 Attraction Modulated by Spacing of Pheromone Components and Anti-attractants in a Bark Beetle and a Moth

13 Anticlastogenic, radiation antagonistic, and anti-inflammatory activities of in albino Wistar rat model.

14 Role of vasopressin V1 antagonist in the action of vasopressin on the cooling-evoked hemodynamic perturbations of rats.

15 Role of vasopressin V1 antagonist in the action of vasopressin on the cooling-evoked hemodynamic perturbations of rats.

16 Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.

17 Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.

18 Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Emergency Reversal of Vitamin K Antagonists: A Meta-Analysis in 2606 Subjects.

19 Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

20 Long-Term Vitamin K Antagonists and Cancer Risk: A Systematic Review and Meta-Analysis.

21 Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention.

22 Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

23 Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients

24 Corrigendum to “Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis” [Arch. Gerontol. Geriatr. 81 (March–April)(2019)209–214](S0167494318302450)(10.1016/j.archger.2018.12.013)

25 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis

26 Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

27 Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study

28 Non-vitamin K antagonist oral anticoagulants with amiodarone, P-glycoprotein inhibitors, or polypharmacy in patients with atrial fibrillation: Systematic review and meta-analysis

29 Efficacy and safety of reduced-dose non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis of randomized controlled trials

30 Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis

31 Outcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysis

32 Use of vitamin K antagonists and risk of prostate cancer: Meta–analysis and nationwide case–control study

33 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis

34 Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis

35 Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis

36 A Systematic Review and Meta-analysis of the Association Between Vitamin K Antagonist Use and Fracture

37 Comment on “Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis”

38 Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

39 Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials

40 Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies

41 DOACs vs Vitamin K Antagonists: a Comparison of Phase III Clinical Trials and a Prescriber Support Tool

42 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

43 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

44 Glucocorticoid Receptor Antagonist Administration Prevents Adrenal Gland Atrophy in an ACTH-Independent Cushing’s Syndrome Rat Model

45 Petroleum degradation by Pseudomonas sp. ZS1 is impeded in the presence of antagonist Alcaligenes sp. CT10

46 Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma

47 Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter ABCG2

48 The effects of angiotensin II receptor antagonist (candesartan) on rat renal vascular resistance

49 Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan

50 Isolation and Characterization of Plant Growth Promoting Antagonistic Bacteria from Cotton and Sugarcane Plants for Suppression of Species.

51 Sigma-1 receptor antagonist, PD144418, selectively reduces female motivation for food during negative energy balance

52 Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist

53 Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model

54 The AMPA receptor binding site: focus on agonists and competitive antagonists.

55 Patent evaluation: Isatine AMPA antagonists

56 Isatine AMPA antagonists

57 Badminton players show a lower coactivation and higher beta band intermuscular interactions of ankle antagonist muscles during isokinetic exercise.

58 Discrete-Time Fractional Order Integral Sliding Mode Control of an Antagonistic Actuator Driven by Pneumatic Artificial Muscles

59 On-chip ion pair-based dispersive liquid-liquid extraction for quantitative determination of histamine H<inf>2</inf> receptor antagonist drugs in human urine

60 Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study

61 An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

62 Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation.

63 QSAR models on H receptor antagonists associated with inflammation and anaphylaxis.

64 Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine.

65 New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.

66 Biological control of chestnut canker, caused by Cryphonectria parasitica, by antagonistic organisms and hypovirulent isolates

67 A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.

68 Bacterial antagonists and hexanal-induced systemic resistance of mango fruits against lasiodiplodia theobromae causing stem-end rot

69 In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.

70 Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.

71 Ribosomal-sequence-directed selection for endophytic streptomycete strains antagonistic to Ralstonia solanacearum to control tomato bacterial wilt

72 The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.

73 Agonist, antagonist and signaling modulators of ABA receptor for agronomic and post-harvest management.

74 Antagonistic interactions and phylogenetic diversity of antimicrobial agents producing marine bacteria in Suez Bay

75 Breeding new sweetpotato genotypes combining elevated content of two antagonistic traits of high dry matter and beta-carotene content in a high root yield background

76 Between an ugly truth and a perfect lie: Wiping off fearful memories using beta-adrenergic receptors antagonists.

77 Antagonistic interplay between pH and food resources affects copepod traits and performance in a year-round upwelling system

78 Efficacy of silicon and titanium nanoparticles biosynthesis by some antagonistic fungi and bacteria for controlling powdery mildew disease of wheat plants

79 [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].

80 Effect of NMDA and AMPA/kainate receptor antagonists against ethambutol induced retinal toxicity using optomotor response (OMR) in goldfish

81 Preclinical optimization of gp120 entry-antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation.

82 Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane hydrochloride (SUVN-911): A Novel, Potent, Selective and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression.

83 Potential antagonistic phylloplane fungi from Stevia rebaudiana Bert. as bio-control of aerial blight disease caused by Rhizoctonia solani

84 Vitamin K antagonist rodenticides display different teratogenic activity.

85 Modulation of post-traumatic immune response using the IL-1 receptor antagonist anakinra for improved visual outcomes.

86 Structural features and functional activities of benzimidazoles as NOD2 antagonists

87 Catalase-mimetic gold nanoparticles inhibit the antagonistic action of toward foodborne enteric pathogens in associative cultures.

88 Antagonists D1 and D2 of Dopamine Receptors Determine Different Mechanisms of Neuroprotective Action in the Frog Vestibular.

89 Mineralocorticoid receptor antagonists for heart failure

90 Cloning, Expression and Purification of Recombinant Interleukin 1 Receptor Antagonist (IL-1RA) in Escherichia coli

91 Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

92 Antagonistic yeasts from a salt-lake region in Egypt: identification of a taxonomically distinct group of phylloplane strains related to Sporisorium

93 Therapeutic Effect of C-C Chemokine Receptor Type 1 (CCR1) Antagonist BX471 on Allergic Rhinitis

94 Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study.

95 aplicaciones en ginecología de los antagonistas de lh-rh

96 18f-labeled grpr agonists and antagonists: a comparative study in prostate cancer imaging

97 novel glun2b selective nmda receptor antagonists: relative configuration of 7-methoxy-2-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-1-ols

98 a high expression egfr/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening egfr antagonists from rhizoma polygoni cuspidati

99 micrornas signatures, bioinformatics analysis of mirnas, mirna mimics and antagonists, and mirna therapeutics in osteosarcoma

100 colletotrichum orbiculare on watermelon: identification and in vitro inhibition by antagonistic fungi

101 follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction

Keyword Connections

Journals

Research Groups

Bibliographies